Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,570 | 47,651 | 22,834 | 35,841 | 39,878 |
| Marketable Securities | 89,024 | 80,071 | 88,259 | 92,325 | 79,228 |
| Receivables | 12,357 | 343 | 325 | 373 | 298 |
| TOTAL | $125,951 | $132,330 | $117,635 | $135,338 | $128,856 |
| Non-Current Assets | |||||
| PPE Net | 1,008 | 1,133 | 1,293 | 1,531 | 1,620 |
| Investments And Advances | 90,302 | 45,714 | 38,778 | 33,199 | 62,771 |
| Other Non-Current Assets | 3,066 | 3,217 | 3,365 | 3,997 | 4,158 |
| TOTAL | $94,376 | $50,064 | $43,436 | $38,727 | $68,549 |
| Total Assets | $220,327 | $182,394 | $161,071 | $174,065 | $197,405 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,690 | 7,662 | 7,269 | 10,810 | 8,878 |
| Accrued Expenses | 20,333 | 4,722 | 5,762 | 6,565 | 19,446 |
| Other current liabilities | 2,683 | N/A | N/A | N/A | 2,628 |
| TOTAL | $31,596 | $18,816 | $15,682 | $20,080 | $30,952 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,890 | 3,765 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 13,139 | 12,245 | 11,567 | 11,971 | 9,274 |
| TOTAL | $33,177 | $33,427 | $11,567 | $11,971 | $9,274 |
| Total Liabilities | $64,773 | $52,243 | $27,249 | $32,051 | $40,226 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 107,919 | 71,431 | 71,345 | 71,265 | 70,925 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -902,861 | -806,309 | -798,723 | -787,737 | -770,796 |
| Other shareholders' equity | 97 | 427 | -463 | -364 | -106 |
| TOTAL | $155,554 | $130,151 | $133,822 | $142,014 | $157,179 |
| Total Liabilities And Equity | $220,327 | $182,394 | $161,071 | $174,065 | $197,405 |